Public Health Link





To:

NHS Trusts - Medical Directors (England)
NHST/FT/007 - NHS FOUNDATION TRUSTS (ENGLAND) - MEDICAL DIRECTOR
Primary Care Trusts - Directors of Public Health
Primary Care Trusts - Medical Directors

Cc (Groups):



Chairman - Professional Executive Committee of PCT
Public Health Link
Regional Directors of Public Health
Strategic Health Authorities (England) - Directors of Public Health

Fax To:




From:

Professor Sir Liam Donaldson - Chief Medical Officer - Department of Health

Date:



27 November 2006



Reference

CEM/CMO/2006/17

Category:

IMMEDIATE (cascade within 6 hours)




Title:

INFORMATION TO HEALTH PROFESSIONALS - RADIOACTIVE MATERIAL ‘POLONIUM-210’ - RADIOLOGICAL INCIDENT IN NOVEMBER 2006






Broadcast Content:

From: Sir Liam Donaldson
Chief Medical Officer, Department of Health

To: Directors of Public Health of PCTs to forward to:
- All GENERAL PRACTITIONERS - please ensure this message is seen by all practice nurses and non-principals working in your practice and retain a copy in your `locum information pack'.
- Deputising services
- Community Paediatricians
- Project manager/Nurse lead in Walk in Centres
- Lead nurses in PCTs and Leads at nurse-led PMS Pilots
- PCT Mental Health Services

To: Medical Directors of NHS Trusts to forward to:
- Accident & Emergency hospital departments
- Clinical Directors

Cc:
- UK CMOs
- Regional Directors of Public Health
- Directors of Public Health of Strategic Health Authorities to forward to:
SHA lead nurses
- Mental Health Leads in SHA
- Chairmen of Professional Executive Committee
- Health Protection Agency
- SHA Emergency Planning Leads



Information to Health Professionals regarding the radioactive material ‘Polonium-210’ resulting from a radiological incident occurring in November 2006.

On 1st November 2006 Alexander Litvinenko was exposed to the alpha emitting radionuclide Po-210. He presented himself to his GP on 3rd November and was transferred to hospital via ambulance.

Members of the public may be concerned that they might have been exposed to radioactivity if they have visited any of the sites that Mr Litvinenko visited, or been in close proximity to Mr Litvinenko himself. The Health Protection Agency has issued a public alert and advice is available through NHS Direct on 0845 4647.

Whilst nothing can be excluded at this stage, it is unlikely that the public or customers of commercial establishments that Mr Litvinenko visited will have had the kind of exposure that would result in acute radiation sickness. A number of people may require long term monitoring of their health.

The enclosed information has been developed by the Health Protection Agency, together with health care professionals of the Department of Health and provides advice on the radioactive material Polonium-210; how it represents a radiation hazard if it is taken into the body by inhalation, ingestion or through wound entry; signs and symptoms of exposure; and confirmation of NHS Direct as a telephone point of contact.

INFORMATION ON A SUSPECTED RADIOLOGICAL INCIDENT
List of pointers to best practice for front line staff


Patient Management

The attached factsheet at Annex A has been developed to identify those patients who have a significant exposure to radioactivity.

If a patient is concerned that they may have been exposed to radioactivity either by being at the sites that the dead patient visited or been in close proximity to the dead patient or his relatives, then they can be considered for testing for radioactivity (faecal sampling or 24 hour urine collection). Please discuss this with the local Health Protection Unit. If demand is high, there may be a time delay as the analysis is complex and there are a few laboratories able to do the analysis.

Signs and Symptoms

At low doses of radiation that are equivalent to whole body doses of up to 1 Gray (equivalent to about 50,000 chest x-rays) there are no acute symptoms. The hazard is an increase in the lifetime risk of cancer that is modest compared to "background" cancer risk.

At higher radiation doses, the patient could experience symptoms of acute radiation syndrome (ARS, see Annex A), however because Po-210 is an alpha emitter, not all of the classical manifestations of ARS would be seen. It is likely that, because the most probable route of intake is ingestion, from contaminated hands, initial symptoms would include gastrointestinal upsets (nausea, vomiting and diarrhoea). These are also the early symptoms of classical ARS. Most ingested Po-210 would pass out of the body in the faeces, if a large dose were absorbed through the gut, this could lead to depletion of the bone marrow with symptoms such as increased susceptibility to infections and bleeding. In this case a blood count would detect the abnormality (which can also be caused by very many other factors).

Contact number for advice

NHS Direct 0845 4647 - the nurse led telephone helpline - offers confidential healthcare advice and information 24 hours a day (website http://www.nhsdirect.nhs.uk).

What is Polonium-210?

Polonium-210 (Po-210) is a radioactive material. It occurs naturally and is present in the environment and in people at very low concentrations. It can also be made by irradiation of other materials.

Polonium-210 has a half-life of 138 days. It undergoes decay by emitting alpha particles, accompanied by very low intensity gamma rays.

Alpha particles do not travel very far - no more than a few centimetres in air. They are stopped by a sheet of paper or by the dead layer of outer skin on our bodies.

Polonium-210 is used industrially, for example in anti-static devices in factories.

Because Polonium-210 is a naturally occurring radionuclide, we all have a very small amount in our bodies. This contributes to the natural radiation dose we all get every year.

What is being done to check for the presence of Polonium-210?

A monitoring programme is underway to determine whether any radioactive Polonium-210 contamination has spread, including in the dead patient’s house and the hospital areas where he was cared for, the Itsu Sushi bar in Piccadilly and the Millennium Hotel in Mayfair.

A checking and monitoring programme is underway for Mr Litvinenko's family and others who may be at risk. This will involve a simple questionnaire and in some cases taking samples of urine for analysis. Individuals who were also in the vicinity of the Itsu Sushi bar and Millennium Hotel on 1st November have been asked to ring the NHS direct phone line for advice.

How might individuals be exposed.

Individuals would not be exposed to radiation simply through being near to a contaminated party. There would be a potential radiological hazard to people who could have ingested or inhaled radioactive material derived from the original source (which at this stage is unknown). They could also have been exposed to contaminated bodily fluids (especially urine, faeces or vomit) from the victim. This latter hazard is likely to be restricted to those who have had very close contact with a contaminated party’s excreta.

Normal hygiene measures will reduce the potential that this will have occurred.

If Polonium-210 is present in the environment, it would need to enter people's bodies to give them a radiation dose, again through ingestion, inhalation or through wound entry.

If anyone has been internally contaminated by inadvertently ingesting or inhaling Polonium-210 from the dead patient, it is most unlikely that they would receive a radiation dose high enough to give rise to medical symptoms.


Annex A

Radiation Facts

Ionising Radiation
• Ionising radiation (invisible, odourless and tasteless) is a form of energy emitted spontaneously by radioactive materials
• Natural radiation is all around us: in air, from cosmic rays; in the earth and building materials; and in food and water – and all of this makes up
the background radiation to which we are all exposed all the time, from conception to death
• Man-made sources of radiation and radioactive materials are used in medicine (diagnostic imaging, radiotherapy), research, widely in industry (nuclear power stations, mining, food irradiation), industrial radiography (eg of pipes, buildings, baggage), smoke detectors and for many other uses including nuclear fuel and nuclear weapons
• Alpha particles, beta particles, gamma rays, X-rays and neutrons are all forms of ionising radiation
• Alpha and beta particles and gamma rays are produced as radioactive materials decay; X-rays are generally man-made
Alpha particles are heavy and highly charged, and interact strongly with atoms. As a result, they lose momentum rapidly, can travel only very short distances and cannot penetrate human skin. Alpha emitters are hazardous only when inhaled, ingested, injected or absorbed (eg through a wound)
Beta particles are also charged, but interact less strongly than alpha particles, so travel further and penetrate more: they can penetrate the dermis.
Clothing, including standard PPE, provides some protection against them. They can cause radiation skin injury on prolonged exposure but are hazardous to internal organs only when inhaled, ingested, injected or absorbed (eg through a wound)
Gamma rays and X-rays are uncharged, so do not interact directly with atoms, and travel many metres in air. They easily penetrate the human body, causing organ damage. Their effects can be attenuated by concrete or lead shielding
Neutrons are uncharged, travel far and penetrate everything (except thick layers of concrete and water), and are highly damaging, but only likely to be produced in the very early stages of a nuclear detonation or accident
Exposure and Contamination
• An exposure occurs when all or part of the body is irradiated
• Three key factors affect exposure: duration, distance and shielding. If the exposure time is halved, the dose is halved. The inverse square law applies to distance: doubling the distance between the source and the body reduces the dose by a factor of 4; trebling the distance between the source and the body reduces the dose by a factor of 9, and so on
• A person is contaminated when radioactive material is deposited on skin and/or clothing (external contamination), or into the body (internal contamination) by inhalation, ingestion (hand-to-mouth, food, drink), or absorption via a wound
• In the same way that a patient who has had a CT scan or X-ray presents no risk to others, radiation safety precautions are NOT needed for patients who have been exposed to radiation but not contaminated
• External contamination – usually dust or particulate matter – is readily removed by decontamination
• Even if a patient is contaminated, the risk of long term health effects for a health professional who uses standard precautions is likely to be tiny, if not trivial
• Radiation is readily detectable with equipment, and contamination is easily measurable. Medical physics, nuclear medicine departments, and front line services have equipment for detecting beta and gamma radiation, and people trained to use it
In a radiation incident:
– Triage and treat life-threatening injury before decontamination; if the patient’s clinical condition permits, decontaminate first, and then treat
– If trauma cases require surgery, perform as soon as possible (and certainly within 48 hours) if dose is more than 1 sievert, or await marrow recovery
Measuring radioactivity and radiation
• Radioactivity (and contamination by radioactive material) is measured in becquerels (1 Bq = 1 disintegration per second)
• The absorbed dose of radiation (the amount of energy absorbed by per unit mass of tissue) is measured in gray (Gy); 1 Gy = 1 joule/kg of tissue
• Different types of radiation have different effects on human tissue (gray for gray, alpha particles and neutrons are more damaging than beta particles, gamma rays or X-rays in terms of the risks of cancer or of heritable genetic defects), so the absorbed dosage is multiplied by a radiation weighting factor to account for this. This gives the equivalent dose (of an organ or tissue), measured in sievert (Sv). For X-rays, gamma rays, and beta particles, the weighting factor = 1, so: 1 gray = 1 sievert = 1,000 millisievert
• Some organs are more radiosensitive than others (eg bone marrow is more sensitive than thyroid), and exposures are rarely uniform. Weighting the equivalent doses received by different organs and tissues during an exposure to allow for each organ’s radiosensitivity, and then summing the results, gives the effective dose
An estimate of the whole body dose is helpful in estimating long term cancer risk
Radiation doses and dose limits
• Chest X-ray: 20 microsievert
• Average annual background radiation in UK: 2.2 millisievert (2,200 microsievert)
• Annual effective dose limit for member of the public: 1 millisievert (1,000 microsievert)
• Annual effective dose limit for radiation worker: 20 millisievert (20,000 microsievert)
• Acute radiation sickness (whole body single dose): 1 sievert and above
• LD50/60 dose killing 50% of those exposed within 60 days if not treated (whole body dose): ~4.5 sievert
CBRN incidents: clinical management & health protection Acute radiation syndrome v1.0 July 2005
Think of radiation exposure
• In any newly diagnosed bone marrow depression (leucopenia: infection; thrombocytopaenia: bleeding gums, nosebleeds, bruising) , or
• ‘Burns’, erythema, or bullae with no history of heat or chemical exposure , or
• Sudden, rapid, hair loss especially if there is a relevant occupational history or unexplained nausea / vomiting +/- diarrhoea 2-4 weeks before onset , and
• When dealing with ANY incident involving a bomb or other intentionally placed explosive device
Overview
• All nuclear and other major sites in the UK have emergency plans and exercise and update them regularly
• On average, there is one serious radiation incident – resulting in death or major radiation injury – in the world each year
• Incidents at major sites will be recognised and managed according to existing plans. However, in the last 50 years there have been more than 200 incidents involving lost, stolen or misused (‘orphan’) sources (eg Lilo, Georgia, 1996-97, 11 trainee border guards exposed to 12 hidden, abandoned, sources had signs and symptoms of radiation injury, but the cause remained unrecognised by doctors for months). The first sign of a problem may be the presentation of a case to an emergency department
• Other concerns include the possibility of exposure from a ‘dirty bomb’ (conventional explosive used to disperse radioactive material), a low yield improvised nuclear device (IND), or a deliberately hidden source of radiation
Acute radiation syndrome
• Many radiation accidents cause partial body injury (early erythema followed by bullae, and, if severe, ulceration and necrosis, often of the hands) and may not be associated with ARS
• ARS follows a large, usually external exposure of all (or most) of the body to penetrating radiation (gamma rays, high-energy X-rays, neutrons) in a short time (seconds, minutes or hours)
• Symptoms of ARS occur in a four-phase sequence: prodromal phase → latent period → illness → recovery/death
• As the radiation dose increases, the prodromal and latent periods shorten. The severity of illness and the risk of mortality increase.
Major trauma and radiation exposure interact synergistically on mortality
• Initial symptoms of ARS are non-specific, and rarely immediately life-threatening; treatment of other injuries takes priority
• If, in the first 6 hours after a suspected exposure, there are no symptoms of exposure (eg nausea, vomiting), serious ARS is unlikely

Symptoms and Signs
Dose: less than 1 sievert
Usually asymptomatic
• Symptoms mild (or absent)
• Episodic nausea, vomiting
in first 48 hours in 1%-10%
• Mildly depressed WBC at
2-4 weeks
• No foetal effects if effective
dose less than 100 millisievert
(100,000 microsievert)
• Counselling needed if
pregnant and effective dose
more than 100 millisievert
(100,000 microsievert
Dose: 1 sievert – 8 sievert
Haematopoietic syndrome
• Anorexia, nausea, vomiting,
fatigue: 1-4 hours after
exposure, timing and
severity dose-related
• Latent period:
2 days-4 weeks
• Bone marrow depression:
leucopenia – infection; low
platelets – bleeding, bruising
• Serial lymphocyte counts in
first 48 hours predict severity
• 3-4 sievert: hair loss at
2-3 weeks
• LD 50/60 is ~4.5 sievert
without treatment
Dose: more than 6 sievert –
20 sievert
Gastrointestinal syndrome
• Early nausea, vomiting,
diarrhoea, anorexia, fatigue
• Latent period: hours-1 week
• Severe gastrointestinal
symptoms (fever, abdominal
pain, cramps, watery
diarrhoea, haemorrhage,
electrolyte imbalance,
dehydration) coupled with
bone marrow depression
• LD100 is about 10 sievert,
death usually within
2 weeks
Dose: more than 20 sievert
CNS/CVS syndrome
• Almost immediate projectile
vomiting, explosive bloody
diarrhoea, headache,
collapse, confusion, loss of
consciousness, agitation,
burning sensation on skin
• May be lucid interval (hours)
• Neurological and
cardiovascular symptoms
predominate: convulsions,
coma, hypotension, shock
• Death within 2-3 days

Management
• Stabilise airway, breathing, circulation, and initiate Rx of any life-threatening conditions (trauma, thermal burns, lung injury)
• Assume all patients are contaminated until you know that they are not: make sure that you, and the area you work in, are protected from possible contamination (see PPE, and radiation facts); reassign pregnant staff; do not handle unfamiliar objects or embedded fragments (eg shrapnel) directly:
use tongs or forceps and place in lead-lined container; remember distance & inverse square law
• Assess contamination using contamination meter. If present, decontaminate, and presume patient may also be internally contaminated
• Removing patient’s clothing (double bag, label and store it securely) can reduce external contamination by as much as 90%
• Symptomatic treatment for nausea, vomiting (cyclizine, odansetron), diarrhoea, pain (opiates), and erythema; monitor and replace fluid loss
• To help assess the dose of radiation received: obtain and record as much information as possible about type and extent of exposure (what? where? when? for how long?); record date, time of onset, and severity of all symptoms and signs; record (body-map, or photograph) sites of any erythema or local injury
• Samples: baseline FBC with serial absolute lymphocyte counts 3-4 hourly for first 12 hours after acute exposure, then 6 hourly for 48 hours; HLA typing (BEFORE transfusing – use irradiated blood products if ARS possible); nasal swabs or nose blows x 2; chromosome analysis (7 ml venous
blood taken 24 hours post exposure into lithium heparin tube); if contamination confirmed, 24 hour urine and faeces
• Seek expert advice early on formal dose assessment and management of internal contamination (medical physics, nuclear medicine, HPA RPD, MoD); infection-prevention regimes, G-CSF and GM-CSF, stem cell/platelet transfusions (haematology, oncology, INM)
• If dose more than 1 sievert and surgery required, do as early as possible (and certainly within 48 hours of exposure) or wait for marrow recovery


Attached below are "Microsoft Word" and "Rich Text Format" versions of the above message.

CMO Health Alert_24 Nov 06_Radiological Incident.docCMO Health Alert_24 Nov 06_Radiological Incident.rtf

Additional Information: